Fulgent Genetics (FLGT) Net Income (2015 - 2026)

Fulgent Genetics has disclosed Net Income across 11 years of filings, most recently posting -$25.3 million for Q1 2026.

• Net Income for Q1 2026 came in at -$25.3 million, down 112.01% year-over-year; the trailing twelve-month figure through Mar 2026 was -$14.3 million (up 61.01% YoY), and the FY2025 annual result was -$1.0 million, up 97.4% from the prior year.
• Net Income came in at -$25.3 million for Q1 2026 at Fulgent Genetics, down from $37.0 million in the prior quarter.
• In the past five years, Net Income ranged from a high of $153.6 million in Q1 2022 to a low of -$25.3 million in Q1 2026.
• The 5-year median for Net Income is -$11.6 million (2023), against an average of $3.6 million.
• Across the five-year window, Net Income plunged 1100.74% in 2023 and soared 3631.52% in 2025, its largest moves.
• Fulgent Genetics' Net Income stood at -$24.1 million in 2022, then soared by 202.09% to $24.6 million in 2023, then tumbled by 104.26% to -$1.0 million in 2024, then jumped by 3631.52% to $37.0 million in 2025, then tumbled by 168.37% to -$25.3 million in 2026.
• The last three Net Income figures came in at -$25.3 million (Q1 2026), $37.0 million (Q4 2025), and -$6.8 million (Q3 2025), per Business Quant data.